Stem cells show promise for relapsing-remitting MS
Autologous non-myeloablative haemopoietic stem cell transplantation may prevent neurological progression and improve neurological disability in patients with relapsing-remitting MS, results of a phase II study show....
Want to read complete article? Please Sign in or Register.